Active Filter(s):
Details:
PP353 is a sustained release formulation of an antibiotic to treat the chronic disc infection, which is designed for intradiscal injection under image guidance.
Lead Product(s): PP353
Therapeutic Area: Musculoskeletal Product Name: PP353
Highest Development Status: Phase I Product Type: Small molecule
Partner/Sponsor/Collaborator: Micron Research Ltd
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable August 19, 2021